D-0392-2026 Class II Ongoing

Recalled by New Life Pharma LLC — Northvale, NJ

FDA drug recall D-0392-2026 was initiated by New Life Pharma LLC on Feb 26, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 820 vials.

Recall details

Product Type
Drugs
Report Date
Mar 11, 2026
Initiation Date
Feb 26, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
820 vials

Product description

Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-07.

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

OH

Code information

Lot 241113, Exp Date 11/30/2026 & Lot 250103, Exp Date 1/31/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0392-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0392-2026. Report a data issue: hello@regdatalab.com.